Skip to main content

Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review

Current Breast Cancer Reports volume 5, pages 222–246 (2013)Cite this article

Abstract

To determine the effectiveness of weight loss intervention for breast cancer survivors. From October 2012 until March 2013, Pubmed was searched for weight loss intervention trials that reported body weight or weight loss as a primary outcome. Fifteen of these studies are included in this review. Of the 15 studies included, 14 resulted in statistically significant weight loss and 10 obtained clinically meaningful weight loss of ≥5 % from baseline. Evidence was provided of the feasibility of using several methods of weight loss intervention (telephone, in person, individual, group). Successful intervention used a comprehensive approach, with dietary, physical activity, and behavior modification components. Weight loss improved cardiovascular risk factors and markers of glucose homeostasis. However, there is insufficient evidence to identify the components of this intervention that led to successful weight loss, or to determine the weight loss necessary to affect biomarkers linked to breast cancer prognosis. The small number of randomized controlled trials shared several limitations, including small study sample sizes and lack of follow-up beyond 6 months. Intervention with longer follow-up revealed weight regain, showing the importance of considering strategies to promote long-term weight maintenance. Weight loss intervention for breast cancer survivors can lead to statistically significant and clinically meaningful weight loss, but the limited number of interventional studies, small sample sizes, and short duration of follow-up in many studies limit our ability to draw conclusions regarding the most efficacious weight-loss intervention after a breast cancer diagnosis. The findings to date are encouraging, but research on the effect of weight loss on breast cancer recurrence and mortality, and on prevention of weight gain for women newly diagnosed with breast cancer, is needed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Organization WH. Breast Cancer: Prevention and Control, World Health Organization (WHO). 2013. 1/13/2013. http://www.who.int/cancer/detection/breastcancer/en/index.html.

  2. Society AC. Cancer Facts & Figures 2013. Atlanta 2013.

  3. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.

    PubMed  Article  Google Scholar 

  4. • Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev Off J Int Assoc Study Obes. 2011;12:282–94. Most women gain weight after diagnosis of breast cancer. Being overweight or obese, and weight gain after diagnosis, are associated with a worse prognosis and greater risk of developing comorbid conditions. Addressing determinants of weight change including prevention of weight gain and sarcopenia is an important topic of future research on breast cancer survival..

    Article  CAS  Google Scholar 

  5. Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111:329–42.

    PubMed  Article  Google Scholar 

  6. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol Off J Am Soci Clin Oncol. 2002;20:1128–43.

    Article  Google Scholar 

  7. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev Off J Int Assoc Study Obes. 2006;7:333–40.

    Article  CAS  Google Scholar 

  8. Anderson AS, Caswell S. Obesity management—an opportunity for cancer prevention. Surg J R Coll Surg Edinb Irel. 2009;7:282–5.

    CAS  Google Scholar 

  9. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol Off J Am Soci Clin Oncol. 2005;23:1370–8.

    Article  Google Scholar 

  10. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.

    PubMed  Article  Google Scholar 

  11. Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat. 2012;134:769–81.

    PubMed  Article  CAS  Google Scholar 

  12. • Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, et al. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2012;21:1260–71. Most women gain weight after diagnosis of breast cancer. Being overweight or obese, and weight gain after diagnosis, are associated with a worse prognosis and greater risk of developing comorbid conditions. Addressing determinants of weight change including prevention of weight gain and sarcopenia is an important topic of future research on breast cancer survival..

    Article  Google Scholar 

  13. Gadea E, Thivat E, Planchat E, Morio B, Durando X. Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms. Obes Rev Off J Int Assoc Study Obes. 2012;13:368–80.

    Article  CAS  Google Scholar 

  14. • Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012;118:2277–87. Most women gain weight after diagnosis of breast cancer. Being overweight or obese, and weight gain after diagnosis, are associated with a worse prognosis and greater risk of developing comorbid conditions. Addressing determinants of weight change including prevention of weight gain and sarcopenia is an important topic of future research on breast cancer survival..

    PubMed  Article  Google Scholar 

  15. Campbell KL, Van Patten CL, Neil SE, Kirkham AA, Gotay CC, Gelmon KA, et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012;112:559–67.

    PubMed  Article  Google Scholar 

  16. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol Off J Am Soci Clin Oncol. 1999;17:2365–70.

    CAS  Google Scholar 

  17. Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol Off J Am Soci Clin Oncol. 1999;17:120–9.

    CAS  Google Scholar 

  18. Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N. Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg. 2006;192:496–8.

    PubMed  Article  CAS  Google Scholar 

  19. Nissen MJ, Shapiro A, Swenson KK. Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin Breast Cancer. 2011;11:52–60.

    PubMed  Article  Google Scholar 

  20. Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, et al. Reducing the weight of cancer: mechanistic targets for breaking the obesity–carcinogenesis link. Best Pract Res Clin Endocrinol Metab. 2008;22:659–69.

    PubMed  Article  CAS  Google Scholar 

  21. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15:556–65.

    PubMed  Article  Google Scholar 

  22. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    PubMed  Article  CAS  Google Scholar 

  23. • Rock CL, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, Wolin KY, et al. Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. Contemp Clin Trials. 2012. The ENERGY trial, the largest study of weight loss intervention for breast cancer survivors, will evaluate a variety of breast cancer outcomes.

  24. de Waard F, Ramlau R, Mulders Y, de Vries T, van Waveren S. A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev. 1993;2:233–8.

    PubMed  Article  Google Scholar 

  25. Djuric Z, DiLaura NM, Jenkins I, Darga L, Jen CK, Mood D, et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res. 2002;10:657–65.

    PubMed  Article  Google Scholar 

  26. Greenlee HA, Crew KD, Mata JM, McKinley PS, Rundle AG, Zhang W, et al. A Pilot Randomized Controlled Trial of a Commercial Diet and Exercise Weight Loss Program in Minority Breast Cancer Survivors. Obesity (Silver Spring). 2012.

  27. Mefferd K, Nichols JF, Pakiz B, Rock CL. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res Treat. 2007;104:145–52.

    PubMed  Article  Google Scholar 

  28. Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, et al. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer. 2013.

  29. Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema. Cancer. 2007;109:1949–56.

    PubMed  Article  Google Scholar 

  30. Stendell-Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, Hakim IA. Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet Off J Br Diet Assoc. 2010;23:590–600.

    Article  CAS  Google Scholar 

  31. Stolley MR, Sharp LK, Oh A, Schiffer L. A weight loss intervention for African American breast cancer survivors, 2006. Prev Chronic Dis. 2009;6:A22.

    PubMed  Google Scholar 

  32. Befort CA, Klemp JR, Austin HL, Perri MG, Schmitz KH, Sullivan DK, et al. Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat. 2012;132:631–9.

    PubMed  Article  Google Scholar 

  33. Goodwin P, Esplen MJ, Butler K, Winocur J, Pritchard K, Brazel S, et al. Multidisciplinary weight management in locoregional breast cancer: results of a phase II study. Breast Cancer Res Treat. 1998;48:53–64.

    PubMed  Article  CAS  Google Scholar 

  34. Thompson HJ, Sedlacek SM, Paul D, Wolfe P, McGinley JN, Playdon MC, et al. Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Res BCR. 2012;14:R1.

    Article  CAS  Google Scholar 

  35. Flynn MM, Reinert SE. Comparing an olive oil-enriched diet to a standard lower-fat diet for weight loss in breast cancer survivors: a pilot study. J Womens Health (Larchmt). 2010;19:1155–61.

    Article  Google Scholar 

  36. Harris MN, Swift DL, Myers VH, Earnest CP, Johannsen NM, Champagne CM, et al. Cancer Survival Through Lifestyle Change (CASTLE): a Pilot Study of Weight Loss. Int J Behav Med. 2012.

  37. Thomson CA, Stopeck AT, Bea JW, Cussler E, Nardi E, Frey G, et al. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr Cancer. 2010;62:1142–52.

    PubMed  Article  CAS  Google Scholar 

  38. Shaw C, Mortimer P, Judd PA. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer. 2007;110:1868–74.

    PubMed  Article  Google Scholar 

  39. Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol Off J Am Soci Clin Oncol. 1993;11:1418–29.

    CAS  Google Scholar 

  40. Kirk SF, Penney TL, McHugh TL, Sharma AM. Effective weight management practice: a review of the lifestyle intervention evidence. Int J Obes (Lond). 2012;36:178–85.

    Article  CAS  Google Scholar 

  41. Moyer VA. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:373–8.

    PubMed  Google Scholar 

  42. Moroshko I, Brennan L, O’Brien P. Predictors of dropout in weight loss interventions: a systematic review of the literature. Obes Rev Off J Int Assoc Study Obes. 2011;12:912–34.

    Article  CAS  Google Scholar 

  43. Pinto BM, Maruyama NC, Clark MM, Cruess DG, Park E, Roberts M. Motivation to modify lifestyle risk behaviors in women treated for breast cancer. Mayo Clinic Proc Mayo Clinic. 2002;77:122–9.

    Google Scholar 

  44. Arem H, Irwin M. A review of web-based weight loss interventions in adults. Obes Rev Off J Int Assoc Study Obes. 2011;12:e236–43.

    Article  CAS  Google Scholar 

  45. Bacigalupo R, Cudd P, Littlewood C, Bissell P, Hawley MS, Buckley Woods H. Interventions employing mobile technology for overweight and obesity: an early systematic review of randomized controlled trials. Obes Rev Off J Int Assoc Study Obes. 2012.

  46. Eakin EG, Lawler SP, Vandelanotte C, Owen N. Telephone interventions for physical activity and dietary behavior change: a systematic review. Am J Prev Med. 2007;32:419–34.

    PubMed  Article  Google Scholar 

  47. Paul-Ebhohimhen V, Avenell A. A Systematic Review of the Effectiveness of Group versus Individual Treatments for Adult Obesity. Obes Facts. 2009;2:17–24.

    PubMed  Article  Google Scholar 

  48. Wu T, Gao X, Chen M, van Dam RM. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev Off J Int Assoc Study Obes. 2009;10:313–23.

    Article  CAS  Google Scholar 

  49. Ackermann RT, Marrero DG. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007; 33: 69, 74–5, 77–8.

    Google Scholar 

  50. Michie S, Johnston M, Francis J, Hardeman W, Eccles M. From theory to intervention: Mapping theoretically derived behavioural determinants to behaviour change techniques. Appl Psychol-Int Rev. 2008;57:660–80.

    Article  Google Scholar 

  51. Fitzgibbon ML, Tussing-Humphreys LM, Porter JS, Martin IK, Odoms-Young A, Sharp LK. Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature. Obes Rev Off J Int Assoc Study Obes. 2012;13:193–213.

    Article  CAS  Google Scholar 

  52. Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002;4:44–9.

    PubMed  Google Scholar 

  53. Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008;8:70–9.

    PubMed  Article  Google Scholar 

  54. Stanley K. Design of randomized controlled trials. Circulation. 2007;115:1164–9.

    PubMed  Article  Google Scholar 

  55. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst. 2013;105:219–36.

    PubMed  Article  CAS  Google Scholar 

  56. Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila). 2012;5:515–21.

    Article  Google Scholar 

  57. Lissner L, Troiano RP, Midthune D, Heitmann BL, Kipnis V, Subar AF, et al. OPEN about obesity: recovery biomarkers, dietary reporting errors and BMI. Int J Obes (Lond). 2007;31:956–61.

    Article  CAS  Google Scholar 

  58. Beechy L, Galpern J, Petrone A, Das SK. Assessment tools in obesity—psychological measures, diet, activity, and body composition. Physiol Behav. 2012;107:154–71.

    PubMed  Article  CAS  Google Scholar 

  59. Health NIo. ClinicalTrials.gov, The United States National Institutes of Health (NIH). 3/11/2013. http://www.clinicaltrials.gov/ct2/results?term=weight+loss+breast+cancer+survivors&Search=Search.

  60. Jen KL, Djuric Z, DiLaura NM, Buison A, Redd JN, Maranci V, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res. 2004;12:306–12.

    PubMed  Article  Google Scholar 

  61. Pakiz B, Flatt SW, Bardwell WA, Rock CL, Mills PJ. Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors. Int J Behav Med. 2011;18:333–41.

    PubMed  Article  Google Scholar 

  62. Sedlacek SM, Playdon MC, Wolfe P, McGinley JN, Wisthoff MR, Daeninck EA, et al. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients (‘CHOICE’): study protocol. BMC Cancer. 2011;11:287.

    PubMed  Article  CAS  Google Scholar 

  63. Arikawa AY, O’Dougherty M, Kaufman BC, Smith AJ, Thomas W, Warren M, et al. Women in Steady Exercise Research (WISER): study design and methods. Contemp Clin Trials. 2010;31:457–65.

    PubMed  Article  Google Scholar 

Download references

Conflict of Interest

M. Playdon declares that she has no conflict of interest.

G. Thomas declares that she has no conflict of interest.

T. Sanft declares that she has no conflict of interest.

M. Harrigan declares that she has no conflict of interest.

J. Ligibel declares that she has no conflict of interest.

M. Irwin declares that she has no conflict of interest.

Author information

Affiliations

  1. Yale School of Public Health, 60 College Street, New Haven, CT, 06520-8034, USA

    Mary Playdon, Gwendolyn Thomas, Maura Harrigan & Melinda Irwin

  2. Yale School of Medicine, New Haven, CT, USA

    Tara Sanft

  3. Dana Farber Cancer Institute, Boston, MA, USA

    Jennifer Ligibel

Authors
  1. Mary Playdon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gwendolyn Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tara Sanft
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maura Harrigan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer Ligibel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Melinda Irwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melinda Irwin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Playdon, M., Thomas, G., Sanft, T. et al. Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review. Curr Breast Cancer Rep 5, 222–246 (2013). https://doi.org/10.1007/s12609-013-0113-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-013-0113-0

Keywords

  • Obesity
  • Overweight
  • Weight
  • Weight loss
  • Physical activity
  • Exercise
  • Diet
  • Nutrition
  • Breast cancer
  • Survival
  • Trial